Profile data is unavailable for this security.
About the company
Fermentalg SA is a France-based industrial biotechnology company. It specializes in the development of a technology which is used to produce molecules of interest and bypasses conventional methods using petrochemicals and also industrial fish farming. The Company offers a solution to the gradual depletion of two key resources: wild fish and petroleum. The Company's technology allows it to target a range of markets, such as human nutrition, animal feed, green chemicals, cosmetics and biofuels.
- Revenue in EUR (TTM)4.06m
- Net income in EUR-14.15m
- Incorporated2009
- Employees62.00
- LocationFermentalg SA4 Rue RiviereLIBOURNE 33500FranceFRA
- Phone+33 557250220
- Websitehttps://www.fermentalg.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plant Advanced Technologies PAT SA | 1.68m | 79.16k | 18.19m | 27.00 | 226.36 | 2.12 | 31.37 | 10.82 | 0.0725 | 0.0725 | 1.54 | 7.73 | 0.1118 | -0.4123 | 1.60 | 62,278.52 | 0.5262 | -3.53 | 0.6534 | -4.39 | 128.03 | 134.21 | 4.71 | -33.16 | 0.4183 | -15.32 | 0.3402 | -- | 8.56 | 8.05 | 119.67 | -38.00 | -- | -- |
| Phaxiam Therapeutics SA | 1.33m | -23.49m | 19.22m | 51.00 | -- | 0.4943 | -- | 14.50 | -5.14 | -5.14 | 0.2901 | 3.90 | 0.0273 | -- | 14.82 | 26,000.00 | -48.37 | -50.69 | -66.94 | -66.25 | -- | -- | -1,771.42 | -1,009.09 | -- | -70.21 | 0.3412 | -- | -80.05 | -21.50 | -10,201.75 | -- | -56.68 | -- |
| Predilife SA | 317.79k | -4.22m | 19.43m | 19.00 | -- | -- | -- | 61.15 | -1.14 | -1.14 | 0.0858 | -1.06 | 0.0695 | -- | 2.05 | 17,030.55 | -92.43 | -89.36 | -129.39 | -123.81 | 97.25 | 83.94 | -1,329.21 | -1,901.22 | -- | -6.23 | 2.20 | -- | 10.11 | 79.85 | -15.58 | -- | -18.51 | -- |
| Oncodesign Precision Medicine Opm SA | 1.07m | -8.09m | 19.46m | 22.00 | -- | 4.82 | -- | 18.15 | -0.4863 | -0.4863 | 0.0645 | 0.2219 | 0.0613 | -- | 1.39 | 48,735.00 | -46.23 | -- | -63.87 | -- | 130.48 | -- | -754.61 | -- | -- | -- | 0.7052 | -- | -86.57 | -- | -3,399.73 | -- | -- | -- |
| Valbiotis SA | 4.73m | -7.37m | 21.32m | 52.00 | -- | 1.09 | -- | 4.51 | -0.5904 | -0.5904 | 0.3798 | 1.24 | 0.1564 | 3.36 | 17.83 | 91,019.23 | -24.35 | -32.92 | -33.77 | -46.36 | 48.76 | 53.15 | -155.67 | -418.87 | 3.38 | -38.19 | 0.2598 | -- | 502.93 | 126.73 | 40.16 | -- | -21.71 | -- |
| Nfl Biosciences SAS | 0.00 | -3.48m | 21.64m | 3.00 | -- | 5.44 | -- | -- | -0.5396 | -0.5396 | 0.00 | 0.4097 | 0.00 | -- | -- | 0.00 | -80.79 | -- | -125.59 | -- | -- | -- | -- | -- | -- | -- | 0.0228 | -- | -- | -- | -149.78 | -- | -- | -- |
| Poxel SA | 1.55m | -44.24m | 30.67m | 30.00 | -- | -- | -- | 19.84 | -1.44 | -1.44 | 0.0507 | -1.22 | 0.0597 | -- | 5.42 | 30,920.00 | -170.71 | -31.97 | -432.50 | -55.94 | 0.1294 | -- | -2,861.58 | -101.47 | -- | -4.08 | 11.28 | -- | -94.97 | -33.77 | -32.13 | -- | -8.49 | -- |
| Gensight Biologics SA | 1.27m | -26.22m | 32.90m | 16.00 | -- | -- | -- | 25.97 | -0.5427 | -0.5427 | 0.0269 | -0.4726 | 0.0723 | -- | 2,534.00 | 79,187.50 | -149.52 | -79.44 | -- | -144.54 | -- | -- | -2,069.53 | -1,036.27 | -- | -- | -- | -- | -50.93 | -- | 5.09 | -- | -58.28 | -- |
| Fermentalg SA | 4.06m | -14.15m | 37.40m | 62.00 | -- | 0.7194 | -- | 9.22 | -0.3176 | -0.3176 | 0.0917 | 0.6033 | 0.0753 | 0.533 | 3.35 | 65,451.61 | -24.63 | -21.94 | -26.79 | -24.71 | 13.21 | 14.73 | -327.08 | -248.95 | 3.53 | -60.94 | 0.3323 | -- | -46.94 | 75.18 | -43.29 | -- | -10.93 | -- |
| genOway SA | 20.05m | 1.57m | 37.47m | 133.00 | 22.68 | 2.15 | 9.34 | 1.87 | 0.1782 | 0.1782 | 2.28 | 1.88 | 0.619 | 0.773 | 3.10 | 150,724.70 | 4.84 | 0.2166 | 6.64 | 0.3048 | 95.82 | 94.82 | 7.82 | 0.4177 | 1.95 | 28.11 | 0.3047 | -- | 17.55 | 13.16 | 101.55 | 22.35 | -- | -- |
| Novacyt SA | 9.36m | -30.07m | 39.86m | 222.00 | -- | 0.3125 | -- | 4.26 | -0.4257 | -0.4271 | 0.1325 | 1.81 | 0.0528 | 1.33 | 0.2622 | 42,140.00 | -16.96 | 17.69 | -20.71 | 23.82 | 43.21 | 62.82 | -321.40 | 23.87 | 4.98 | -79.02 | 0.0036 | 0.00 | -77.28 | 13.49 | -269.46 | -- | -13.46 | -- |
| Abionyx Pharma SA | 4.64m | -3.52m | 43.31m | 61.00 | -- | 5.04 | -- | 9.34 | -0.121 | -0.121 | 0.1581 | 0.246 | 0.3027 | 21.86 | 4.20 | 76,694.22 | -22.95 | -18.82 | -32.52 | -28.87 | 13.32 | 14.32 | -75.82 | -128.54 | 1.70 | -- | 0.2997 | -- | -11.65 | 92.84 | 16.36 | -- | 41.40 | -- |
Data as of Jul 30 2024. Currency figures normalised to Fermentalg SA's reporting currency: Euro EUR
4.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Moneta Asset Management SASas of 27 Oct 2023 | 2.39m | 2.72% |
| OFI Invest Asset Management SAas of 31 Aug 2023 | 400.00k | 0.46% |
| AXA Investment Managers (Paris) SAas of 31 May 2024 | 315.00k | 0.36% |
| HSBC Global Asset Management (France) SAas of 31 May 2024 | 243.39k | 0.28% |
| Chaussier Gestion SAas of 28 Jun 2024 | 140.00k | 0.16% |
| FPM Frankfurt Performance Management AGas of 30 Apr 2024 | 100.00k | 0.11% |
| Friedland Gestion SASas of 22 Mar 2024 | 19.90k | 0.02% |
| BlackRock Investment Management (UK) Ltd.as of 31 Jan 2022 | 6.94k | 0.01% |
| Claresco Finance SAas of 30 Jun 2023 | 0.00 | 0.00% |
| Gestys SAas of 31 May 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 28 Jun 2024Source: FactSet Research Systems Inc.
